GWIN — Reska Biotech Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMicro Cap

Annual balance sheet for Reska Biotech, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2013 March 31st	2014 March 31st	C2015 March 31st	2016 March 31st	2017 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0	—	0.214	0	0
Net Total Accounts Receivable
Net Total Receivables	0.031	0	0.463	0	0
Total Inventory
Total Other Current Assets
Total Current Assets	0.031	0	3.42	0	0
Net Property, Plant And Equipment	0	—	—	—	—
Total Assets	0.031	0	3.42	0	0
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.048	0.017	0.766	0.033	0.099
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.048	0.017	0.766	0.033	0.099
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.017	-0.017	2.66	-0.033	-0.099
Total Liabilities & Shareholders' Equity	0.031	0	3.42	0	0
Total Common Shares Outstanding